Pub Date : 2026-01-02DOI: 10.1016/j.jbiotec.2025.12.019
Mingyang Hu , Chongpeng Bi , Yuwen Li, Yutong Xue, Sina Cha, Lu Zhao, Chenyu Xue, Na Dong
The rising prevalence of antibiotic resistance underscores the urgent need for alternative strategies to manage pathogenic bacteria. Engineered probiotics offer a promising platform for delivering antimicrobial peptides (AMPs); however, their practical application remains constrained by challenges related to maintaining viability and in vivo functionality. This study focused on two main aspects: (1) optimizing a freeze-drying strategy for Lactococcus lactis/pNZC-Usp45-H-6 ×His (L. L/HI), which expresses the AMP HI targeting Escherichia coli, and (2) evaluating its protective efficacy against enterotoxigenic Escherichia coli (ETEC) infection in a murine model. Sorbitol at a concentration of 6 % (w/v) was identified as the most effective cryoprotectant for preserving bacterial viability after freeze-drying. In the ETEC infection model, oral administration of L. L/HI significantly alleviated intestinal injury by reducing bacterial colonization and lipopolysaccharide levels, alleviating inflammation, and restoring the expression of tight junction genes. Moreover, L. L/HI downregulated the expression of pro-inflammatory cytokines (TNF-α, IL-1β, IL-6) and upregulated the anti-inflammatory cytokine IL-10 in ileal tissues. These findings demonstrate that oral administration of L. L/HI reduced the bacterial burden in the ileum of ETEC–infected mice and indirectly alleviated inflammation and intestinal barrier damage caused by ETEC infection. This study provides a novel approach for the translational application of engineered probiotics.
抗生素耐药性的日益流行突出表明迫切需要采取其他战略来管理致病菌。工程益生菌为提供抗菌肽(amp)提供了一个有前途的平台;然而,它们的实际应用仍然受到与维持活力和体内功能相关的挑战的限制。本研究主要集中在两个方面:(1)优化以大肠杆菌为靶点表达AMP HI的乳酸乳球菌/pNZC-Usp45-H-6×His (L. L/HI)的冷冻干燥策略;(2)在小鼠模型上评价其对产肠毒素大肠杆菌(ETEC)感染的保护作用。山梨醇在6% (w/v)的浓度下被确定为冷冻干燥后保持细菌活力最有效的冷冻保护剂。在ETEC感染模型中,口服L. L. /HI通过减少细菌定植和脂多糖水平、减轻炎症、恢复紧密连接基因的表达,显著减轻肠道损伤。L. L/HI下调回肠组织中促炎因子(TNF-α、IL-1β、IL-6)的表达,上调抗炎因子IL-10的表达。上述结果表明,口服L. L/HI可减轻ETEC感染小鼠回肠细菌负荷,间接减轻ETEC感染引起的炎症和肠屏障损伤。本研究为工程益生菌的转化应用提供了新的途径。
{"title":"Engineered Lactococcus lactis expressing antimicrobial peptide HI: Enhanced survival and protection against ETEC in mice","authors":"Mingyang Hu , Chongpeng Bi , Yuwen Li, Yutong Xue, Sina Cha, Lu Zhao, Chenyu Xue, Na Dong","doi":"10.1016/j.jbiotec.2025.12.019","DOIUrl":"10.1016/j.jbiotec.2025.12.019","url":null,"abstract":"<div><div>The rising prevalence of antibiotic resistance underscores the urgent need for alternative strategies to manage pathogenic bacteria. Engineered probiotics offer a promising platform for delivering antimicrobial peptides (AMPs); however, their practical application remains constrained by challenges related to maintaining viability and <em>in vivo</em> functionality. This study focused on two main aspects: (1) optimizing a freeze-drying strategy for <em>Lactococcus lactis/</em>pNZC-Usp45-H-6 ×His (<em>L. L</em>/HI), which expresses the AMP HI targeting <em>Escherichia coli</em>, and (2) evaluating its protective efficacy against enterotoxigenic <em>Escherichia coli</em> (ETEC) infection in a murine model. Sorbitol at a concentration of 6 % (w/v) was identified as the most effective cryoprotectant for preserving bacterial viability after freeze-drying. In the ETEC infection model, oral administration of <em>L. L</em>/HI significantly alleviated intestinal injury by reducing bacterial colonization and lipopolysaccharide levels, alleviating inflammation, and restoring the expression of tight junction genes. Moreover, <em>L. L</em>/HI downregulated the expression of pro-inflammatory cytokines (TNF-α, IL-1β, IL-6) and upregulated the anti-inflammatory cytokine IL-10 in ileal tissues. These findings demonstrate that oral administration of <em>L. L</em>/HI reduced the bacterial burden in the ileum of ETEC–infected mice and indirectly alleviated inflammation and intestinal barrier damage caused by ETEC infection. This study provides a novel approach for the translational application of engineered probiotics.</div></div>","PeriodicalId":15153,"journal":{"name":"Journal of biotechnology","volume":"410 ","pages":"Pages 331-340"},"PeriodicalIF":3.9,"publicationDate":"2026-01-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145900309","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-29DOI: 10.1016/j.jbiotec.2025.12.018
Xiaoyu Zhang , Jiayue Guan , Yanqi Yang , Shangci Zuo , Chang Liu , Pengchao Wang
Ergothioneine (EGT) is a rare sulfur-containing derivative of methionine with potent antioxidant, anti-inflammatory, and neuroprotective properties. Its unique bioactivities make it a promising ingredient for applications in functional foods, nutraceuticals, and cosmetics. Microbial fermentation offers a sustainable alternative to extraction from natural sources, yet challenges such as precursor limitations, cofactor imbalances, and pathway complexity continue to restrict industrial-scale production. In this study, we engineered Escherichia coli (E. coli) as a microbial chassis for efficient de novo synthesis of EGT. By co-expressing key enzymes derived from bacteria and fungi, enhancing cysteine biosynthesis, and improving methionine utilization, we addressed key bottlenecks in precursor supply. Furthermore, the introduction of a methylation cycle significantly improved the regeneration of S-adenosylmethionine (SAM), relieving cofactor limitations. These combined metabolic engineering strategies led to a substantial increase in EGT production. The final engineered strain achieved a titer of 141.3 mg/L in shake flasks, representing a sixfold improvement over the base strain. In a 5-liter fed-batch fermentation, the titer reached 1.95 g/L without precursor supplementation and further increased to 2.52 g/L upon low-dose amino acid feeding. This work establishes a cost-effective and scalable biosynthetic platform for EGT production in E. coli, offering a viable route for its application in food and health-related industries.
{"title":"Construction of an E. coli cell factory for ergothioneine through SAM-cycle enhancement and pathway reconstruction","authors":"Xiaoyu Zhang , Jiayue Guan , Yanqi Yang , Shangci Zuo , Chang Liu , Pengchao Wang","doi":"10.1016/j.jbiotec.2025.12.018","DOIUrl":"10.1016/j.jbiotec.2025.12.018","url":null,"abstract":"<div><div>Ergothioneine (EGT) is a rare sulfur-containing derivative of methionine with potent antioxidant, anti-inflammatory, and neuroprotective properties. Its unique bioactivities make it a promising ingredient for applications in functional foods, nutraceuticals, and cosmetics. Microbial fermentation offers a sustainable alternative to extraction from natural sources, yet challenges such as precursor limitations, cofactor imbalances, and pathway complexity continue to restrict industrial-scale production. In this study, we engineered <em>Escherichia coli</em> (<em>E. coli</em>) as a microbial chassis for efficient de novo synthesis of EGT. By co-expressing key enzymes derived from bacteria and fungi, enhancing cysteine biosynthesis, and improving methionine utilization, we addressed key bottlenecks in precursor supply. Furthermore, the introduction of a methylation cycle significantly improved the regeneration of S-adenosylmethionine (SAM), relieving cofactor limitations. These combined metabolic engineering strategies led to a substantial increase in EGT production. The final engineered strain achieved a titer of 141.3 mg/L in shake flasks, representing a sixfold improvement over the base strain. In a 5-liter fed-batch fermentation, the titer reached 1.95 g/L without precursor supplementation and further increased to 2.52 g/L upon low-dose amino acid feeding. This work establishes a cost-effective and scalable biosynthetic platform for EGT production in <em>E. coli</em>, offering a viable route for its application in food and health-related industries.</div></div>","PeriodicalId":15153,"journal":{"name":"Journal of biotechnology","volume":"410 ","pages":"Pages 298-308"},"PeriodicalIF":3.9,"publicationDate":"2025-12-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145878348","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-24DOI: 10.1016/j.jbiotec.2025.12.017
Fei-yan Cheng , Long-wei Lou , Zong-lin Li , Zhi-min Li
Cyanophycin, also known as cyanophycin granule polypeptide (CGP), was a natural polyamide synthesized via a nonribosomal pathway from L-aspartic acid and L-arginine. Its derived dipeptide, β-Asp-Arg, holds potential applications in various fields requiring arginine supplementation in feed or food industries. However, conventional CGP production methods were constrained by strict substrate specificity and high costs. To address these challenges, two-step enzymatic cascade system was constructed integrating CGP biosynthesis with dipeptide production. Central to this system is a novel cyanophycin synthetase (CphA1) from Acidobacteria bacterium, which exhibits remarkable substrate promiscuity. This enzyme enables both primer-independent polymerization of poly-L-Arg/L-Lys-poly(L-Asp) backbones and primer-dependent incorporation of non-canonical substrates (L-ornithine and L-citrulline), thereby expanding the repertoire of cyanophycin derivatives. Furthermore, polyphosphate kinase synergizes with CphA1 to regenerate ATP and promote CGP synthesis, reducing ATP consumption by 90 %. Subsequently, the polymer was efficiently hydrolyzed by CphB from Geminocystis herdmanii to yield the target dipeptides. This method achieved complete conversion of CGP into classical dipeptides β-Asp-Arg and β-Asp-Lys, with the highest titer reaching 80 mM, while also generating non-classical products β-Asp-Orn and β-Asp-Cit. These results highlight the robustness and versatility of this strategy, offering a promising route for the scalable synthesis of β-Asp-basic amino acid dipeptides.
藻青素又称藻青素颗粒多肽(CGP),是由l -天冬氨酸和l -精氨酸经非核糖体途径合成的天然聚酰胺。其衍生的二肽β-Asp-Arg在饲料或食品工业中需要精氨酸补充的各种领域具有潜在的应用前景。然而,传统的CGP生产方法受到严格的底物特异性和高成本的限制。为了解决这些问题,我们构建了将CGP生物合成与二肽生产相结合的两步酶级联系统。该系统的核心是一种来自酸杆菌的新型蓝藻素合成酶(CphA1),它表现出显著的底物混杂性。该酶既可以独立于引物的聚l -精氨酸/ l -赖氨酸聚(L-Asp)骨架聚合,也可以依赖于引物的非规范底物(l -鸟氨酸和l -瓜氨酸)的结合,从而扩大了蓝藻素衍生物的范围。此外,多磷酸激酶与CphA1协同再生ATP,促进CGP合成,减少90%的ATP消耗。随后,该聚合物被来自herdmanii的CphB高效水解,以产生目标二肽。该方法实现了CGP完全转化为经典二肽β-Asp-Arg和β-Asp-Lys,最高滴度达到80mM,同时还生成了非经典产物β-Asp-Orn和β-Asp-Cit。这些结果突出了该策略的稳健性和多功能性,为大规模合成β- asp -碱性氨基酸二肽提供了一条有前途的途径。
{"title":"In vitro synthesis of β-aspartyl-basic amino acid dipeptides via a multi-enzyme cascade system with ATP regeneration","authors":"Fei-yan Cheng , Long-wei Lou , Zong-lin Li , Zhi-min Li","doi":"10.1016/j.jbiotec.2025.12.017","DOIUrl":"10.1016/j.jbiotec.2025.12.017","url":null,"abstract":"<div><div>Cyanophycin, also known as cyanophycin granule polypeptide (CGP), was a natural polyamide synthesized via a nonribosomal pathway from <span>L</span>-aspartic acid and <span>L</span>-arginine. Its derived dipeptide, β-Asp-Arg, holds potential applications in various fields requiring arginine supplementation in feed or food industries. However, conventional CGP production methods were constrained by strict substrate specificity and high costs. To address these challenges, two-step enzymatic cascade system was constructed integrating CGP biosynthesis with dipeptide production. Central to this system is a novel cyanophycin synthetase (CphA1) from <em>Acidobacteria bacterium</em>, which exhibits remarkable substrate promiscuity. This enzyme enables both primer-independent polymerization of poly-<span>L</span>-Arg/<span>L</span>-Lys-poly(<span>L</span>-Asp) backbones and primer-dependent incorporation of non-canonical substrates (<span>L</span>-ornithine and <span>L</span>-citrulline), thereby expanding the repertoire of cyanophycin derivatives. Furthermore, polyphosphate kinase synergizes with CphA1 to regenerate ATP and promote CGP synthesis, reducing ATP consumption by 90 %. Subsequently, the polymer was efficiently hydrolyzed by CphB from <em>Geminocystis herdmanii</em> to yield the target dipeptides. This method achieved complete conversion of CGP into classical dipeptides β-Asp-Arg and β-Asp-Lys, with the highest titer reaching 80 mM, while also generating non-classical products β-Asp-Orn and β-Asp-Cit. These results highlight the robustness and versatility of this strategy, offering a promising route for the scalable synthesis of β-Asp-basic amino acid dipeptides.</div></div>","PeriodicalId":15153,"journal":{"name":"Journal of biotechnology","volume":"410 ","pages":"Pages 276-284"},"PeriodicalIF":3.9,"publicationDate":"2025-12-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145843647","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-23DOI: 10.1016/j.jbiotec.2025.12.016
Maryam Ehsasatvatan , Bahram Baghban Kohnehrouz
The growing world population and the increasing demand for proteins present significant challenges to food security. Advances in synthetic biology have enabled the development of transplastomic plants engineered to produce milk proteins, offering a promising solution for the large-scale, economical production of alternative protein sources. This study demonstrated the extended stability of human α-lactalbumin (hLA) in freeze-dried transplastomic tobacco chloroplasts. hLA was expressed at high levels, constituting 39.1 % of the total soluble protein in chloroplasts (66.5 mg/g isolated chloroplasts). Western blot analysis of lyophilized tobacco chloroplasts stored at room temperature for up to six months indicated that the hLA protein remained stable, soluble, and properly folded over extended periods. The freeze-drying process of isolated chloroplasts resulted in a 34-fold increase in hLA protein concentrations. Importantly, the biological functionality of purified hLA from lyophilized chloroplasts was confirmed through an in vitro lactose synthesis assay, where recombinant hLA successfully activated galactosyltransferase, leading to efficient lactose production at level comparable to commercial standard. Lyophilized chloroplasts, free from nicotine and bacterial contamination, are suitable candidates for the oral administration of the dietary protein alpha-lactalbumin. These findings suggest that recombinant protein production in transplastomic plants could serve as a viable food source and alternative to conventional sources. Lyophilization further reduces expenses and streamlines downstream processing, purification, and storage. These methods facilitate relevant formulation practices for these compounds to meet the demand-oriented requirements. Future research should prioritize translation of this technology to edible plant hosts to enable direct human consumption and undertake comprehensive in vivo and clinical studies to validate safety, bioavailability, and efficacy.
{"title":"Lyophilized chloroplasts as molecular capsules: A scalable platform for stable and functional human α-lactalbumin production","authors":"Maryam Ehsasatvatan , Bahram Baghban Kohnehrouz","doi":"10.1016/j.jbiotec.2025.12.016","DOIUrl":"10.1016/j.jbiotec.2025.12.016","url":null,"abstract":"<div><div>The growing world population and the increasing demand for proteins present significant challenges to food security. Advances in synthetic biology have enabled the development of transplastomic plants engineered to produce milk proteins, offering a promising solution for the large-scale, economical production of alternative protein sources. This study demonstrated the extended stability of human α-lactalbumin (hLA) in freeze-dried transplastomic tobacco chloroplasts. hLA was expressed at high levels, constituting 39.1 % of the total soluble protein in chloroplasts (66.5 mg/g isolated chloroplasts). Western blot analysis of lyophilized tobacco chloroplasts stored at room temperature for up to six months indicated that the hLA protein remained stable, soluble, and properly folded over extended periods. The freeze-drying process of isolated chloroplasts resulted in a 34-fold increase in hLA protein concentrations. Importantly, the biological functionality of purified hLA from lyophilized chloroplasts was confirmed through an <em>in vitro</em> lactose synthesis assay, where recombinant hLA successfully activated galactosyltransferase, leading to efficient lactose production at level comparable to commercial standard. Lyophilized chloroplasts, free from nicotine and bacterial contamination, are suitable candidates for the oral administration of the dietary protein alpha-lactalbumin. These findings suggest that recombinant protein production in transplastomic plants could serve as a viable food source and alternative to conventional sources. Lyophilization further reduces expenses and streamlines downstream processing, purification, and storage. These methods facilitate relevant formulation practices for these compounds to meet the demand-oriented requirements. Future research should prioritize translation of this technology to edible plant hosts to enable direct human consumption and undertake comprehensive <em>in vivo</em> and clinical studies to validate safety, bioavailability, and efficacy.</div></div>","PeriodicalId":15153,"journal":{"name":"Journal of biotechnology","volume":"410 ","pages":"Pages 266-275"},"PeriodicalIF":3.9,"publicationDate":"2025-12-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145834083","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-19DOI: 10.1016/j.jbiotec.2025.12.007
Nazgul Wagner, Jonas Austerjost, Julia Niemann
Adeno-associated virus (AAV) vectors are recognized as highly efficient carriers for genetic material. Among the various manufacturing platforms, transient production is the most established one for AAV production. Despite this, the transient production is influenced by numerous variables that can significantly impact the outcome. In this study, we employed 15 ml multi-parallel scale-down bioreactor system to evaluate critical process parameters like cell densities and plasmid DNA concentration. Additionally, a 250 ml bioreactor system was used to explore factors, such as bioprocess mode, comparing batch versus perfusion processes under optimized conditions. Results showed that in low cell density AAV production, where cell specific productivity is highest, the perfusion process yielded over three-fold lower functional titers compared to the batch process at 37°C. Furthermore, the impact of temperature-shifts, a yield improvement strategy that is rarely explored in the context of AAV production, was examined, resulting in increased functional AAV yields - almost two-fold in batch process and over three-fold increase in perfusion process. The temperature-shift not only increased total number of functional AAV particles but also improved the ratio of functional to capsid titers, suggesting enhanced encapsidation or reduced genomic loss from filled particles. After identifying the optimal setup, the process was successfully scaled up to a benchtop bioreactor, demonstrating the scalability and reproducibility of the optimized process. Production results were rapidly assessed using high-throughput analytical techniques, evaluating capsid titers via the biolayer interferometry (BLI)-based Octet® platform and functional titers through an in vitro assay using the high-throughput imaging-based Incucyte® system.
{"title":"Multi-parameter process optimization for high yield AAV2 vector production using scale-down multi-parallel bioreactor systems and high-throughput analytical tools","authors":"Nazgul Wagner, Jonas Austerjost, Julia Niemann","doi":"10.1016/j.jbiotec.2025.12.007","DOIUrl":"10.1016/j.jbiotec.2025.12.007","url":null,"abstract":"<div><div>Adeno-associated virus (AAV) vectors are recognized as highly efficient carriers for genetic material. Among the various manufacturing platforms, transient production is the most established one for AAV production. Despite this, the transient production is influenced by numerous variables that can significantly impact the outcome. In this study, we employed 15 ml multi-parallel scale-down bioreactor system to evaluate critical process parameters like cell densities and plasmid DNA concentration. Additionally, a 250 ml bioreactor system was used to explore factors, such as bioprocess mode, comparing batch versus perfusion processes under optimized conditions. Results showed that in low cell density AAV production, where cell specific productivity is highest, the perfusion process yielded over three-fold lower functional titers compared to the batch process at 37°C. Furthermore, the impact of temperature-shifts, a yield improvement strategy that is rarely explored in the context of AAV production, was examined, resulting in increased functional AAV yields - almost two-fold in batch process and over three-fold increase in perfusion process. The temperature-shift not only increased total number of functional AAV particles but also improved the ratio of functional to capsid titers, suggesting enhanced encapsidation or reduced genomic loss from filled particles. After identifying the optimal setup, the process was successfully scaled up to a benchtop bioreactor, demonstrating the scalability and reproducibility of the optimized process. Production results were rapidly assessed using high-throughput analytical techniques, evaluating capsid titers via the biolayer interferometry (BLI)-based Octet® platform and functional titers through an <em>in vitro</em> assay using the high-throughput imaging-based Incucyte® system.</div></div>","PeriodicalId":15153,"journal":{"name":"Journal of biotechnology","volume":"410 ","pages":"Pages 228-235"},"PeriodicalIF":3.9,"publicationDate":"2025-12-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145804653","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-19DOI: 10.1016/j.jbiotec.2025.12.015
Xiaopeng Guo , Xiuyue Xiao , Xuexia Dong , Runsheng Yin , Shengli Zhang , Miaomiao Zhang , Guanghong Luo , Yonggang Wang , Dong Lu
Efficient microbial mutagenesis using heavy-ion beam (HIB) radiation is crucial for breeding. Here, Saccharomyces cerevisiae was irradiated with HIB across medium and high doses. Based on 65 randomly selected isolates, we systematically characterized the mutagenic features and preliminarily explored the influence of gene transcriptional activity on mutation susceptibility, while also modulating the intracellular state to optimize strain breeding. High-dose irradiation (120–210 Gy) resulted in a mutation frequency more than double that of the medium-dose (90 Gy), with minimal overlapping mutations between doses. Although mutation site numbers correlated with chromosome length broadly, they were not uniformly distributed at a finer scale. The overall expression of genes associated with mutation sites moderately exceeded the genome-wide background level (p < 0.05). By coupling radiation with osmotic stress, osmoregulatory-related genes were induced to express highly during irradiation. The proportion of osmotolerant mutants obtained from each coupled treatment group (averaging 27.62 %) was higher than that from the radiation-only group (11.43 %). Inference and validation indicated that early selection pressure alone could not fully account for this improvement, highlighting the importance of the intracellular state. Compared to radiation alone, coupled radiation-osmotic stress increased the distribution of mutations in osmotically inducible osmoregulatory-related genes. We propose that the enhanced transcriptional activity may alter local chromatin conformation, together with pre-activation of shared osmotic-radiation response genes, reshape the damage-repair-mutagenesis balance. The coupled treatment produced genetically stable, highly osmotolerant mutants with mutations synergistically regulating carbon metabolism, ion homeostasis, cell adhesion, and DNA replication. This work supports developing high-efficiency microbial breeding strategies.
{"title":"Heavy ion beam irradiation-induced mutational profiles in Saccharomyces cerevisiae and their dependencies on dose and intracellular state inform an enhanced microbial breeding strategy","authors":"Xiaopeng Guo , Xiuyue Xiao , Xuexia Dong , Runsheng Yin , Shengli Zhang , Miaomiao Zhang , Guanghong Luo , Yonggang Wang , Dong Lu","doi":"10.1016/j.jbiotec.2025.12.015","DOIUrl":"10.1016/j.jbiotec.2025.12.015","url":null,"abstract":"<div><div>Efficient microbial mutagenesis using heavy-ion beam (HIB) radiation is crucial for breeding. Here, <em>Saccharomyces cerevisiae</em> was irradiated with HIB across medium and high doses. Based on 65 randomly selected isolates, we systematically characterized the mutagenic features and preliminarily explored the influence of gene transcriptional activity on mutation susceptibility, while also modulating the intracellular state to optimize strain breeding. High-dose irradiation (120–210 Gy) resulted in a mutation frequency more than double that of the medium-dose (90 Gy), with minimal overlapping mutations between doses. Although mutation site numbers correlated with chromosome length broadly, they were not uniformly distributed at a finer scale. The overall expression of genes associated with mutation sites moderately exceeded the genome-wide background level (<em>p</em> < 0.05). By coupling radiation with osmotic stress, osmoregulatory-related genes were induced to express highly during irradiation. The proportion of osmotolerant mutants obtained from each coupled treatment group (averaging 27.62 %) was higher than that from the radiation-only group (11.43 %). Inference and validation indicated that early selection pressure alone could not fully account for this improvement, highlighting the importance of the intracellular state. Compared to radiation alone, coupled radiation-osmotic stress increased the distribution of mutations in osmotically inducible osmoregulatory-related genes. We propose that the enhanced transcriptional activity may alter local chromatin conformation, together with pre-activation of shared osmotic-radiation response genes, reshape the damage-repair-mutagenesis balance. The coupled treatment produced genetically stable, highly osmotolerant mutants with mutations synergistically regulating carbon metabolism, ion homeostasis, cell adhesion, and DNA replication. This work supports developing high-efficiency microbial breeding strategies.</div></div>","PeriodicalId":15153,"journal":{"name":"Journal of biotechnology","volume":"410 ","pages":"Pages 236-257"},"PeriodicalIF":3.9,"publicationDate":"2025-12-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145804626","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Glycosylation of natural products significantly enhances their physicochemical properties, with glycosyltransferases (GTs) serving as the catalytic core of this biotransformation. Rational design of tailored GTs aligned with green chemistry principles is pivotal for the targeted synthesis of high-value glycosides, yet precise functional engineering remains challenging. This study employed a multi-scale computational strategy (molecular docking, multiple sequence alignment, molecular dynamics simulations) to systematically re-engineer the substrate recognition and stability modules of the bacterial GT BsGT-1. By reverse-engineering the active pocket of a plant-derived hyperpromiscuous GT (FiGT-2), we orthogonally mapped and identified six functional hotspots in BsGT-1. Site-directed mutagenesis and screening yielded the double variant S128T/T229S, achieving dual optimization: improved substrate scope (121–140 % increase in conversion with UDP-Gal/UDP-Rha compared to wild-type) and enhanced thermostability (>70 % residual activity after 4 h at 50℃). Structural dynamics analyses revealed that mutation-induced global conformational rigidity and localized hydrogen-bond network optimization primarily drove thermostability improvement and substrate affinity enhancement, respectively. This work establishes a closed-loop engineering paradigm of "computational prediction → rational mutagenesis → mechanistic decoding", providing a scalable framework for precision engineering of GTs and glycoside biomanufacturing.
{"title":"Rational design of a bifunctional glycosyltransferase for enhanced substrate promiscuity and thermostability","authors":"Dekai Liu , Ruifang Zhang , Peiqin Chen , Chunying Jin , Lingzhi Zhang , Xiao Gu , Li Wen , Lijuan Zhang , Guangya Zhang , Zhongkun Wu , Wei Jiang","doi":"10.1016/j.jbiotec.2025.12.009","DOIUrl":"10.1016/j.jbiotec.2025.12.009","url":null,"abstract":"<div><div>Glycosylation of natural products significantly enhances their physicochemical properties, with glycosyltransferases (GTs) serving as the catalytic core of this biotransformation. Rational design of tailored GTs aligned with green chemistry principles is pivotal for the targeted synthesis of high-value glycosides, yet precise functional engineering remains challenging. This study employed a multi-scale computational strategy (molecular docking, multiple sequence alignment, molecular dynamics simulations) to systematically re-engineer the substrate recognition and stability modules of the bacterial GT BsGT-1. By reverse-engineering the active pocket of a plant-derived hyperpromiscuous GT (FiGT-2), we orthogonally mapped and identified six functional hotspots in BsGT-1. Site-directed mutagenesis and screening yielded the double variant S128T/T229S, achieving dual optimization: improved substrate scope (121–140 % increase in conversion with UDP-Gal/UDP-Rha compared to wild-type) and enhanced thermostability (>70 % residual activity after 4 h at 50℃). Structural dynamics analyses revealed that mutation-induced global conformational rigidity and localized hydrogen-bond network optimization primarily drove thermostability improvement and substrate affinity enhancement, respectively. This work establishes a closed-loop engineering paradigm of \"computational prediction → rational mutagenesis → mechanistic decoding\", providing a scalable framework for precision engineering of GTs and glycoside biomanufacturing.</div></div>","PeriodicalId":15153,"journal":{"name":"Journal of biotechnology","volume":"410 ","pages":"Pages 285-297"},"PeriodicalIF":3.9,"publicationDate":"2025-12-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145804717","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-18DOI: 10.1016/j.jbiotec.2025.12.014
Anum Jamil , Aleena Zahid , Rafaqat Ali Khan , Muhammad Saleem , Syed Mujtaba Ul Hassan , Shahzad Anwar , Qura Tul Ain
Photodynamic therapy (PDT) and antibacterial Photodynamic therapy (aPDT) have become a viable non-invasive treatment against cancer and bacterial infections. By using light-activated photosensitizers (PS), PDT effectively destroys cancer cells and pathogenic bacteria. However, many PS agents, such as Aluminum Phthalocyanine chloride (AlPc), face limitations like poor solubility and low bioavailability. To overcome these challenges, AlPc-loaded PLGA nanoparticles (AlPc NPs) have been synthesized, where PS is encapsulated in Poly (lactic-co-glycolic acid) (PLGA) to enhance drug delivery and therapeutic efficacy. PLGA was selected for its well-established biomedical applications, including targeted drug delivery and antibacterial activity. This study focuses on synthesizing 200 nm AlPc NPs by using the single emulsion solvent evaporation method and characterizing them via spectroscopic and microscopic techniques. This study demonstrates that AlPc NPs' encapsulation efficiency is 82 % and drug loading efficiency is 10 %. The drug release profile shows 52 % release of AlPc NPs within 24 h. Cellular uptake of free AlPc and AlPc NPs was examined using confocal fluorescence imaging. The in vitro investigation used Hep-2C human laryngeal cancer cells to assess the dark and phototoxic effects of free AlPc and AlPc NPs for PDT. MTT results show that the cells treated with AlPc NPs had lower cell viability than cells treated with free AlPc at the same drug doses, which confirms improved efficacy of AlPc NPs. Moreover, AlPc NPs improved the antibacterial potential against the Escherichia coli (E. coli) bacterial strain and increased their bioavailability.
{"title":"Aluminum phthalocyanine chloride loaded poly (lactic-co-glycolic acid) nanoparticles based photodynamic therapy for antibacterial and anticancer applications","authors":"Anum Jamil , Aleena Zahid , Rafaqat Ali Khan , Muhammad Saleem , Syed Mujtaba Ul Hassan , Shahzad Anwar , Qura Tul Ain","doi":"10.1016/j.jbiotec.2025.12.014","DOIUrl":"10.1016/j.jbiotec.2025.12.014","url":null,"abstract":"<div><div>Photodynamic therapy (PDT) and antibacterial Photodynamic therapy (aPDT) have become a viable non-invasive treatment against cancer and bacterial infections. By using light-activated photosensitizers (PS), PDT effectively destroys cancer cells and pathogenic bacteria. However, many PS agents, such as Aluminum Phthalocyanine chloride (AlPc), face limitations like poor solubility and low bioavailability. To overcome these challenges, AlPc-loaded PLGA nanoparticles (AlPc NPs) have been synthesized, where PS is encapsulated in Poly (lactic-co-glycolic acid) (PLGA) to enhance drug delivery and therapeutic efficacy. PLGA was selected for its well-established biomedical applications, including targeted drug delivery and antibacterial activity. This study focuses on synthesizing 200 nm AlPc NPs by using the single emulsion solvent evaporation method and characterizing them via spectroscopic and microscopic techniques. This study demonstrates that AlPc NPs' encapsulation efficiency is 82 % and drug loading efficiency is 10 %. The drug release profile shows 52 % release of AlPc NPs within 24 h. Cellular uptake of free AlPc and AlPc NPs was examined using confocal fluorescence imaging. The in vitro investigation used Hep-2C human laryngeal cancer cells to assess the dark and phototoxic effects of free AlPc and AlPc NPs for PDT. MTT results show that the cells treated with AlPc NPs had lower cell viability than cells treated with free AlPc at the same drug doses, which confirms improved efficacy of AlPc NPs. Moreover, AlPc NPs improved the antibacterial potential against the <em>Escherichia coli (E. coli)</em> bacterial strain and increased their bioavailability.</div></div>","PeriodicalId":15153,"journal":{"name":"Journal of biotechnology","volume":"410 ","pages":"Pages 309-320"},"PeriodicalIF":3.9,"publicationDate":"2025-12-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145800443","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-16DOI: 10.1016/j.jbiotec.2025.12.011
Linhai Xie , Shuo Tian , Zhehao Jin , Tiantian Zou , Mingxin Chang , Hongting Tang , Tao Yu , Zhoukang Zhuang
As an emerging alternative protein, Single cell protein (SCP) has gained considerable traction in livestock feed applications. Furthermore, it presents substantial potential for replacing traditional dietary proteins for human consumption. Yet current research remains focused on strain screening with limited advances in cellular metabolic engineering. Due to the complexity of protein synthesis and processing, enhancing the SCP production efficiency in microbial chassis remains a major challenge. Here, we present a metabolic engineering approach to systematic engineer the cell wall of Saccharomyces cerevisiae for improving SCP production. In this study, we constructed a strain by gene modifications of genes related to cell wall biogenesis and associated signaling pathways, achieving a 32.6 % increase in cellular protein content. Additionally, comparative transcriptomics analysis uncovered the regulatory mechanism whereby remodeling of carbon and nitrogen metabolism governs cellular protein biosynthesis, providing new insight for the rational design of microbial cell factories with enhanced protein content.
{"title":"Systematic engineering of cell wall for improving single cell protein (SCP) production","authors":"Linhai Xie , Shuo Tian , Zhehao Jin , Tiantian Zou , Mingxin Chang , Hongting Tang , Tao Yu , Zhoukang Zhuang","doi":"10.1016/j.jbiotec.2025.12.011","DOIUrl":"10.1016/j.jbiotec.2025.12.011","url":null,"abstract":"<div><div>As an emerging alternative protein, Single cell protein (SCP) has gained considerable traction in livestock feed applications. Furthermore, it presents substantial potential for replacing traditional dietary proteins for human consumption. Yet current research remains focused on strain screening with limited advances in cellular metabolic engineering. Due to the complexity of protein synthesis and processing, enhancing the SCP production efficiency in microbial chassis remains a major challenge. Here, we present a metabolic engineering approach to systematic engineer the cell wall of <em>Saccharomyces cerevisiae</em> for improving SCP production. In this study, we constructed a strain by gene modifications of genes related to cell wall biogenesis and associated signaling pathways, achieving a 32.6 % increase in cellular protein content. Additionally, comparative transcriptomics analysis uncovered the regulatory mechanism whereby remodeling of carbon and nitrogen metabolism governs cellular protein biosynthesis, providing new insight for the rational design of microbial cell factories with enhanced protein content.</div></div>","PeriodicalId":15153,"journal":{"name":"Journal of biotechnology","volume":"410 ","pages":"Pages 173-183"},"PeriodicalIF":3.9,"publicationDate":"2025-12-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145781399","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-16DOI: 10.1016/j.jbiotec.2025.12.012
Bochun Hu , Xiaoqi Xi , Qianjin Hou , Jiaxin Ou , Xiaoxuan Shen , Zining Wang , Jiahui Zhao , Cunduo Tang , Jihong Huang
To eliminate the requirement for pyruvate supplementation and to avoid lactate accumulation, a multi-enzyme cascade was systematically restructured by replacing lactate dehydrogenase (LDH) with water-forming NADH oxidase (EfNOx). In this revised system, RpEHL360V catalyzed the enantioconvergent hydrolysis of rac-4-chlorostyrene oxide (rac-1a) to (R)-1-(4-chlorophenyl)-1,2-ethanediol (1b), followed by stereoselective oxidation of (R)-1b to 4’-chloro-2-hydroxyacetophenone (1c) by BsBDHAI49L/V266L/G292A. Concurrently, EfNOx reduced molecular oxygen to water, regenerating NAD+ and sustaining redox balance. To further enhance intracellular cofactor turnover, BsBDHAI49L/V266L/G292A and EfNOx were co-expressed in Escherichia coli, generating the recombinant strain E. coli/Cbn. Through single-factor and L9(33) orthogonal array optimization, the one-pot in vivo cascade achieved maximal efficiency with lyophilized whole cells of E. coli/rpehL360V (5 mg DCW/mL) and E. coli/Cbn (35 mg DCW/mL) in sodium phosphate buffer (10 mM, pH 7.0) containing 5 mM NAD+ and 5 % (v/v) Tween-20 at 25 °C for 8 h under controlled agitation and aeration. Under these conditions, 25 mM rac-1a was converted to 1c with a yield of 92.1 % and a space-time yield (STY) of 2.9 mmol/L/h, representing a 3.7-fold increase relative to the original LDH-based system. The applicability of the cascade was further demonstrated using additional substrates (rac-2a to rac-7a), yielding the corresponding α-hydroxyketones at 39.1–94.5 % with STYs of 1.2–3.0 mmol/L/h. These findings establish BDH–NOx co-expression as a robust strategy for cofactor self-sufficiency and provide a scalable framework for the efficient in vivo synthesis of structurally diverse α-hydroxyketones.
{"title":"Engineered BDH–NOx co-expression in Escherichia coli enables highly efficient in vivo cascade catalysis for the transformation of racemic epoxides to α-hydroxyketones","authors":"Bochun Hu , Xiaoqi Xi , Qianjin Hou , Jiaxin Ou , Xiaoxuan Shen , Zining Wang , Jiahui Zhao , Cunduo Tang , Jihong Huang","doi":"10.1016/j.jbiotec.2025.12.012","DOIUrl":"10.1016/j.jbiotec.2025.12.012","url":null,"abstract":"<div><div>To eliminate the requirement for pyruvate supplementation and to avoid lactate accumulation, a multi-enzyme cascade was systematically restructured by replacing lactate dehydrogenase (LDH) with water-forming NADH oxidase (<em>Ef</em>NOx). In this revised system, <em>Rp</em>EH<sup>L360V</sup> catalyzed the enantioconvergent hydrolysis of <em>rac</em>-4-chlorostyrene oxide (<em>rac</em>-<strong>1a</strong>) to (<em>R</em>)-1-(4-chlorophenyl)-1,2-ethanediol (<strong>1b</strong>), followed by stereoselective oxidation of (<em>R</em>)-<strong>1b</strong> to 4’-chloro-2-hydroxyacetophenone (<strong>1c</strong>) by <em>Bs</em>BDHA<sup>I49L/V266L/G292A</sup>. Concurrently, <em>Ef</em>NOx reduced molecular oxygen to water, regenerating NAD<sup>+</sup> and sustaining redox balance. To further enhance intracellular cofactor turnover, <em>Bs</em>BDHA<sup>I49L/V266L/G292A</sup> and <em>Ef</em>NOx were co-expressed in <em>Escherichia coli</em>, generating the recombinant strain <em>E. coli</em>/C<em>bn</em>. Through single-factor and L9(3<sup>3</sup>) orthogonal array optimization, the one-pot <em>in vivo</em> cascade achieved maximal efficiency with lyophilized whole cells of <em>E. coli/rpeh</em><sup>L360V</sup> (5 mg DCW/mL) and <em>E. coli</em>/C<em>bn</em> (35 mg DCW/mL) in sodium phosphate buffer (10 mM, pH 7.0) containing 5 mM NAD<sup>+</sup> and 5 % (v/v) Tween-20 at 25 °C for 8 h under controlled agitation and aeration. Under these conditions, 25 mM <em>rac</em>-<strong>1a</strong> was converted to <strong>1c</strong> with a yield of 92.1 % and a space-time yield (STY) of 2.9 mmol/L/h, representing a 3.7-fold increase relative to the original LDH-based system. The applicability of the cascade was further demonstrated using additional substrates (<em>rac</em>-<strong>2a</strong> to <em>rac</em>-<strong>7a</strong>), yielding the corresponding α-hydroxyketones at 39.1–94.5 % with STYs of 1.2–3.0 mmol/L/h. These findings establish BDH–NOx co-expression as a robust strategy for cofactor self-sufficiency and provide a scalable framework for the efficient <em>in vivo</em> synthesis of structurally diverse α-hydroxyketones.</div></div>","PeriodicalId":15153,"journal":{"name":"Journal of biotechnology","volume":"410 ","pages":"Pages 184-193"},"PeriodicalIF":3.9,"publicationDate":"2025-12-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145781375","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}